Fundraising FoxSofinnova Ventures — Full Portfolio
222 tracked investments · page 2 of 2 · listed companies and verified rows first
BiotechLa Jolla, US
Allison E. Hulme(Executive Officer, Director)inRandall E. Woods(Executive Officer, Director)inPeter T. Slover(Executive Officer)Gerald T Proehl(Director)John E Geltosky(Director)Jim E. Heppell(Director)
Spark Therapeutics, now part of the Roche Group, focuses on delivering therapies to improve patient outcomes and create healthier communities.
BiotechDigital HealthHealthtechMedical Devices
Co-investorsFountain Healthcare Partners
TriusRX is a health information platform that provides curated articles, guides, and resources covering nutrition, mental wellness, chronic conditions, and preventative care.
Digital HealthHealthtechWellness & Fitness
Sarah Bennett(Founder)
A biopharmaceutical company developing medicines and vaccines with a focus on clinical research and development for human health.
BiotechSan Diego, US
David Johnson(Executive Officer, Director)Cam Gallagher(Director)Scott L. Glenn(Director)in
Co-investorsChiesi VenturesDecheng CapitalPappas CapitalVedanta CapitalViking GlobalArix Bioscience+4 more
Vesalius Therapeutics develops a computational platform that identifies distinct disease subtypes within common diseases like heart failure, diabetes, and Alzheimer's by analyzing patient data and gene circuits, then uses proprietary cell-based models to discover targeted drug candidates.
AI & Machine LearningBiotechDeep TechCambridge, US
Yasir Al-Wakeel(CEO)in
Co-investorsFlagship PioneeringARCH Venture Partners
XyloCor Therapeutics develops gene therapies for advanced coronary artery disease and cardiac damage.
BiotechHealthtechMedical DevicesMalvern, US
Ronald Crystal(Founder and Advisor (Board Observer))Todd Rosengart(Founder; Board Observer)John Tucker(President and CEO)Albert Gianchetti(Executive Officer, Director)
BoardGlenn Batchelder(Director)inJames Cohen(Director)
Co-investorsLumira VenturesFountain Healthcare PartnersJeito CapitalLongwood Fund
Y-mAbs develops radioimmunotherapy and antibody-based therapies targeting pediatric and adult cancers, with a heritage in high-risk neuroblastoma and expansion into additional oncology indications.
BiotechDigital HealthHealthtechMedical Devices
Thomas Gad(Founder, Vice Chairman of the Board of Directors, and Chief Business Officer)in
BiotechCoppell, US
Alvaro F. Guillem(Executive Officer, Director)Todd Creech(Executive Officer)Donald Jeffrey Keyser(Executive Officer, Director)Cynthia Smith(Executive Officer)Henrick Sandvad Rasmussen(Executive Officer)Robert Alexander(Executive Officer, Director)
Co-investorsRiverVest Venture Partners
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Sorbent TherapeuticsSpark TherapeuticsSybios CorporationSyros PharmaceuticalsTensysmedicalTransgenomicTranslate BioTSROVera TherapeuticsVersartisVicepttxVion PharmaceuticalsVisen Pharma
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.